Multimodal trans-scale biomedical imaging facility
A Chinese national science infrastructure at Huairou Science City integrating several imaging modalities into one cluster to build domestic high-end imaging instruments — approved 2018, construction from 2019, trial operation 2023, performance acceptance 2024.
1 · What it gives
The Multimodal Trans-Scale Biomedical Imaging Facility is a major national science-and-technology infrastructure project in China integrating multiple imaging modalities. It is designed to promote domestic production of high-end biomedical imaging instruments in place of imported equipment. Milestones: project approval in 2018, construction from 2019, trial operation in 2023 and performance acceptance in 2024.
2 · What it replaces 6
3 · How to implement 3 steps
- 1ApprovalObtain project approval (2018).
- 2ConstructionBuild the facility (from 2019).
- 3Trial operation and acceptanceRun trial operation (2023) and performance acceptance (2024).
4 · Who delivers
Matched suppliers (matched automatically)
| Insect Science | South Africa | Producer | active |
| McJones Energy | Ghana | Services / consulting | active |
| NARO | Uganda | Research / RTO | active |
| PTT Global Chemical (GC) | Thailand | Research / RTO | active |
| Prometheus Materials | United States | Research / RTO | active |
| Rodenburg Biopolymers | Netherlands | Producer | active |
| Wetlands Construidos | Brazil | Services / consulting | active |
| Becton Dickinson | United States | Producer | active |
| Danaher | United States | Producer | active |
| Dassault Systemes | France | Producer | active |
| Genmab | Denmark | Producer | active |
| Regeneron Pharmaceuticals | United States | Producer | active |
Leading companies and institutes (from the brief)
The project is led by Peking University with the Institute of Biophysics of the Chinese Academy of Sciences as co-builder, with partners including Harbin Institute of Technology. Instrument makers are matched by the portal under Research tools & R&D services.
5 · Rules & route to market
declaration; up to ~6-7 months if biodegradability claims need testing
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
It is a state-level project under China’s 13th Five-Year Plan, approved and overseen by the National Development and Reform Commission.
6 · Money: tenders & grants
7 · Tech stack & innovations
Main technical challenge from the sources: breaking through scale barriers by integrating several imaging modalities into one seamless cluster.
Sources 4
- Hsc.beijing.gov.cn — hsc.beijing.gov.cn 2026-10-16
- Hsc.beijing.gov.cn — hsc.beijing.gov.cn 2026-10-16
- Ndrc.gov.cn — www.ndrc.gov.cn 2026-10-16
- Nbic.pku.edu.cn — nbic.pku.edu.cn 2026-10-16